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Human Papillomavirus
Lauren Leathers BSN, RN, C-EFM, CCE
Otterbein University, Westerville, Ohio
Introduction
Human Papillomavirus (HPV) is the
most common sexually transmitted
infection (STI) across the United
States with approximately 42.5% of
Americans aged 18-59 infected with
the virus and approximately 14
million new cases of HPV each year
(CDC, 2017). Numerous variations of
this disease exist, leading to diverse
symptoms and reactions. Depending
on the strain, HPV can remain labile
or transient for those infected;
however, other strains of HPV can
lead to lifelong consequences as
great as death in some patients
(Mirabello et al, 2018).
Approximately 485,000 cases of
cervical cancer related to high-risk
HPV strains were diagnosed globally
in 2008; 236,000 of these cervical
cancer patients died that same year
(Mirabello et al, 2018). There is a
vaccination to protect patients from
four of the major high-risk cancer or
genital wart causing strains of HPV,
but completion of this vaccination
series across individuals in the
United States is lower than
anticipated. Healthy People 2020
includes a goal of 80% of all males
and females between the ages of 1315 complete the HPV vaccination
series (ODPHP, 2018). However, as
of 2015, only 42 percent of girls and
28 percent of boys in this age group
have been administered all three
doses of this series (CDC, 2017). Due
to its virality and prevention
capability, HPV is a hot topic of
interest amongst health providers
that continues to be explored.

Underlying Pathophysiology

Transmission
▸ HPV is contracted through direct skin to
skin contact in both males and females
(CDC, 2016).
▸ Transmission is typically from oral, vaginal
or anal sexual activity (CDC, 2016).
▸ Increased likelihood of infection can occur
due to: promiscuity, having sexual contact
with an individual who has had multiple sex
partners, initiation of sexual activity at an
early age, and lack of circumcision (Rigaud,
2015).

Signs and Symptoms
▸ Over 200 forms of HPV have been identified
(Mirabello et al, 2018).
▸ Amongst these types, HPV is classified into
”high” or “low” risk categories based on the
ability to become cancerous (Soto, Song, &
McLaughlin-Drubin, 2017).
▸ High-risk strains are often persistent and
can lead to genital, anal or oral cancers (Soto
et al, 2017).
▸ The more typical carcinogenic variations of
HPV include high risk strains, such as HPV
16 and 18 (Crosignani et al, 2013).
▸ Low risk HPVs are typically transient or
cause little to no symptoms (Crosignani et al,
2013).
▸ Low risk strains such as HPV 6 and 11 may
also cause minor symptoms such as genital
warts (Crosignani et al, 2013).
▸ Many individuals do not know they have
HPV (Rigaud, 2015).
▸ Approximately 70% of HPV infections are
cleared within one year, and 90% of
infections are cleared at 2 years (Rigaud,
2015).
▸ Often cervical diagnosis of HPV occurs
through routine cervical cytology testing, or
a Pap smear, in women. Otherwise, HPV may
not be identified until cancerous lesions or
warts are found (Rigaud, 2015).
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Human Papillomaviruses are microscopic, DNA pathogens
that invade the body through small tears or abrasions in
epithelial tissue such as the cervix, oropharynx, and skin
(Crosignani et al, 2013).
HPV cells infect basal keratinocytes located in the
basement layer of the tissue’s stratified squamous
epithelium (Crosignani et al, 2013).
E6 and E7 oncogenes found within these HPV cells disrupt
the normal function of cellular p53 and retinoblastoma
proteins, leading to increased production of abnormal
basal cells (Soto et al, 2017).
Continued replication of HPV infected basal cells leads to
disorganization in the epithelial structure as these cells
continue to proliferate and mature (Mirabello et al, 2018).
For most individuals, the body interrupts such an HPV
infection through immune system recognition and
intervention. HPV infections can be eliminated within 2
years of exposure (Rigaud, 2015).
However, persistent HPV infection can lead to more
critical, carcinogenic results (Crosignani et al, 2013).

Significance

Nursing Implications

▸ High risk HPVs are known to cause
approximately 5% of all human cancers
(Soto et al, 2017).
▸ American men and women are
diagnosed with approximately 33.369
HPV related cancers each year
(Crosignani et al, 2013).
▸ HPV is also now known as the direct
cause for greater than 95% of all cervical
cancer cases, the 3rd leading cancer
amongst women (Mirabello et al, 2018).
▸ HPV carcinogenic lesion progression is
slow. Cancerous lesions may not be
symptomatic or identified until 10-15
years following initial infection
(Crosignani et al, 2013).
▸ Without early detection and
intervention, cancerous lesions resulting
from HPV infection may be lethal in
some patients (Mirabello et al, 2018).

▸ As healthcare providers, HPV
prevention can be facilitated through
regular screening, patient education and
vaccination.
▸ Screening done through cervical Pap
smears are recommended every 3 years
for women aged 21-65 (Rigaud, 2015).
▸ Musa et al found that women exposed to
HPV education were 2.5 times more
likely to attend routine Pap smears for
cervical disease screening (2017).
▸ A vaccination series called “Gardasil 9”
exists to prevent 9 of the most common
high risk and genital wart causing HPV
strains. This series is either 2 or 3 steps
depending on age initiation (Merck
Sharp & Dohme Corp., 2017).
▸ Initiating the HPV vaccination at an
early age prior to sexual contact is key
to prevent HPV infection. Gardasil 9
may be administered from ages 9-26
(Merck Sharpe & Dohme Corp., 2017).
▸ Population completion of the Gardasil 9
series has been less than hoped. Due to
issues such as the complexity of the
multi-step dosing, low perceived risk
and stigma of sexual intimacy
discussion for younger adolescents,
Garbutt et al finds challenges to Gardasil
administration (2018).
▸ No cure exists for HPV infections
(Rigaud, 2015).

Conclusions
Human Papillomavirus is a common
pathogen affecting American people. Per
the CDC, approximately 80 percent of all
people will have some form of HPV during
their lifetime (2016). Though most strains
of HPV are temporary and seemingly
harmless, other more virulent strains may
cause complications such as cancer of the
cervix, penis, anus, or oropharynx.
Prevention and detection are key.
Education on the disease and vaccination
using Gardasil 9 are essential for providers
to implement amongst patients,
particularly parents and adolescents.
Continued screening through annual Pap
smears are also important for early
identification of HPV causing cervical
cancers in women.
The photo above illustrates the HPV infection process at the cellular level (Kahn, 2009).

References:

